Thank you to our speakers, sponsors, and delegates who joined us in
2024 for the summit!
If you are interested in the 2025 event, please get in touch info@hansonwade.com
2023 welcomed SV95C as the first-ever digital endpoint qualified by a regulatory agency, which meant that the floodgates opened to the potential of digital biomarkers to transform clinical development in neurology.
From the latest validated research on implementing speech, cognition, and motor tracking measures into clinical development, to navigating the regulatory and commercial landscape, the Digital Biomarkers & Clinical Measures in Neurology Summit is the ultimate platform to take digital strategy to the next level.
This August, senior industry leaders across digital health, medical affairs, clinical development, and regulatory gathered in Boston for three days of expert insights from the likes of Biogen, DEEP Measures, Janssen, Alexion Pharmaceuticals, Pfizer, Novo Nordisk, Novartis, Boehringer Ingelheim, Takeda, MTP, BMS, Alto Neurosciences, Michael J. Fox Foundation, Cerevel Therapeutics, Regeneron and many more…
Expert Speakers Sharing Exclusive Insights and Real-Life Case Studies
Key Industry Stakeholders Joining Across the Full 3 Days
Jam-Packed Days of Unmissable Content and Industry Networking